Metabolic syndrome is a clustering of abdominal obesity, insulin resistance, dyslipidemia and elevated blood pressure. A global increase int he incidence and prevalence of Metabolic Syndrome has been noted. IN line with this, blindness caused by retinopathy both diabetic or hypertensive has also been a rising concern because of the increasing number of individuals who develop retinopathy syndrome would have a greater risk for developing retinopathy compared to patients who do not present with metabolic syndrome.
This is a cross-sectional study involving 87 persons aged 40 and above seen in the Internal Medicine Outpatient Department. These patients were classified according to the presence or absence of metabolic syndrome using the ATP III criteria. An indirect fundoscopy as done to detect presence or absence of retinopathy. To determine the association between metabolic syndrome and retinopathy among participants, computation of odds ratio was used.
87 patients were included int he study. 50 patients were noted to have metabolic syndrome and 37 patients did not fulfill the criteria for metabolic syndrome. 24% of patients with metabolic syndrome have retinopathy and only 10.8% of patients without metabolic syndrome are 2.6 times more likely to have retinopathy than those without metabolic syndrome, however this was found to be not significant (OR 2.6 C 0.8,8.9).
Retinopathy was noted to be more prevalent among patients with metabolic syndrome compared to patients without metabolic syndrome. Although the results were not statistically significant, we documented an increase in the risk of developing retinopathy among patients with metabolic syndrome compared to patients without metabolic syndrome (OC 2.6 CI 0.8, 8.9)